The fast-growing biotechnology industry in Cuba has created a new cancer drug called Cimavax. The drug targets epidermal growth cells and allows the body to attack the cancer on its own. Cancer patients who use the drug are expected to live 3 to 5 months longer. Yet, patients in the United States have limited access to the new treatment. The United States has imposed a trade embargo on Cuba that prevents the importation of goods such as medication and, therefore, requires patients to travel to Cuba in order to receive the new treatment.
From NYTimes.com, “A Souvenir Smuggled Home From Cuba: A Cancer Vaccine”
Excerpt from article:
“The trial could take years, but American cancer patients are not waiting. Over the past couple of years, dozens have slipped into Havana and smuggled vials of the vaccine in refrigerated lunchboxes back to the United States, sometimes not even telling their doctors. Talk about Cimavax on cancer patient networks online has been escalating steadily as relations between the two countries have warmed and more patients are making preparations to go…”
Tags: Cancer, Treatment, News, Research